HepaTx Corporation
PrivateLast Round
Grant
May 20, 2025
Est. Valuation
$2.14M
Total Funding Raised
$475,032
Company Overview
HepaTx Corporation is a biotechnology company that specializes in regenerative medicine and the development of stem cell-based therapies for patients with late-stage liver disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HepaTx Corporation Comparables
Compare HepaTx Corporation with similar companies based on industry and business-model similarity.
HepaTx Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 20, 2025 | ||||
| Seed | May 1, 2021 | ||||
| Grant | Sep 1, 2019 | ||||
| Accelerator | Aug 21, 2018 |
HepaTx Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartX | Accelerator |
| NIH RADx | Grant |
| Bioverge | Seed |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Y Combinator | Accelerator |
| Sand Hill Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2025
$176K grant from National Institute of Diabetes and Digestive and Kidney Diseases.
HepaTx Corporation Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HepaTx Corporation's valuation, stock price, and market status.